Peptide Monitoring Profile (8–12 weeks)
RecommendedPrivate Peptide Monitoring Profile in London for £249, designed for follow-up testing around 8–12 weeks, with results in approximately 1 business day.
Turnaround time
1 business day
Biomarkers count
22
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinic.full_address }}
{{ selectedClinic.full_address }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the Peptide Monitoring Profile (8–12 weeks)
The Peptide Monitoring Profile (8–12 weeks) is a targeted follow-up blood test designed to review important hormonal, metabolic, thyroid, kidney, cardiovascular, nutritional and inflammatory markers during a peptide-related or longevity protocol.
The profile contains 22 listed biomarkers and laboratory profiles, including Total and Free Testosterone, SHBG, Oestradiol, DHEA-S, IGF-1, thyroid hormones, fasting glucose and insulin, HOMA-IR, HbA1c, kidney function, a lipid profile, Vitamin D, Magnesium, Zinc, hs-CRP, Prolactin and Progesterone.
Testing at around 8–12 weeks can provide a useful comparison with baseline results and help identify laboratory changes that may warrant further review. However, the appropriate monitoring interval depends on the substances being used, dose, medical history, symptoms and clinical supervision. Blood testing cannot establish that a peptide product is genuine, sterile, safe or appropriate for an individual.
The results are most useful when compared with a pre-treatment or baseline blood test and interpreted by a suitably qualified healthcare professional who understands the protocol being followed.
What Does the Peptide Monitoring Profile Contain?
This profile includes 22 biomarkers and laboratory assessments covering thyroid function, sex hormones, growth-factor signalling, glucose and insulin regulation, kidney function, cardiovascular health, vitamins, minerals and inflammation.
TSH - Measures Thyroid Stimulating Hormone, the pituitary hormone responsible for regulating thyroid hormone production. Changes in TSH should be considered alongside FT3 and FT4 rather than interpreted alone.
FT3 - Measures Free T3, the biologically active thyroid hormone involved in metabolism, energy expenditure, temperature regulation and other physiological processes.
FT4 - Measures Free T4, the principal circulating thyroid hormone produced by the thyroid gland and available to body tissues.
Free Testosterone - Assesses the proportion of testosterone available to tissues rather than testosterone that is tightly bound to circulating proteins.
Total Testosterone - Measures the overall concentration of testosterone circulating in the blood and provides information relevant to androgen status.
Sex Hormone Binding Globulin (SHBG) - Measures a protein that binds testosterone and Oestradiol and influences how much circulating hormone remains biologically available.
Oestradiol - Measures a major form of oestrogen present in both women and men. Interpretation depends on sex, age, menstrual status where applicable, medication and the wider hormone profile.
DHEA-S - Measures dehydroepiandrosterone sulphate, an adrenal hormone that acts as a precursor to several other steroid hormones.
Prolactin - Measures a hormone produced by the pituitary gland that interacts with reproductive and sex-hormone pathways.
Progesterone - Measures progesterone, a steroid hormone whose interpretation varies considerably according to sex, menstrual cycle stage, pregnancy status and hormonal treatment.
IGF-1 - Measures Insulin-Like Growth Factor 1, a hormone influenced by growth hormone signalling and involved in growth, tissue metabolism and other physiological processes. Results require age-specific interpretation and should not be used alone to assess growth hormone activity.
Fasting Glucose - Measures the concentration of glucose in the blood after an appropriate fasting period and provides information about current blood sugar regulation.
Fasting Insulin - Measures circulating insulin while fasting and can provide additional information about the amount of insulin required to maintain fasting glucose levels.
HOMA-IR - Provides a calculated estimate of insulin resistance using fasting glucose and fasting insulin. It is most useful when both measurements are collected under appropriate fasting conditions.
HbA1c - Reflects average blood glucose exposure over approximately the previous two to three months and provides information about longer-term glucose regulation.
Creatinine - Measures a waste product produced during normal muscle metabolism and commonly used when assessing kidney filtration.
eGFR - Provides an estimated measure of kidney filtration based principally on Creatinine together with relevant demographic and laboratory factors.
LIPP - The Lipid Profile assesses cholesterol and triglyceride-related markers and provides information relevant to cardiovascular and metabolic health.
Vitamin D - Measures Vitamin D status, which is relevant to bone health, calcium regulation, muscle function and several other physiological processes.
Magnesium - Measures an essential mineral involved in nerve signalling, muscle contraction, energy metabolism and electrolyte balance.
Zinc - Measures an essential trace mineral involved in immune function, protein synthesis, tissue repair and numerous enzyme pathways.
hs-CRP - Measures low concentrations of C-reactive protein and provides information about systemic inflammatory activity. It is non-specific and can be temporarily affected by infection, illness, injury and strenuous exercise.
Who May Benefit From the Peptide Monitoring Profile ?
This test may be suitable for people who are already following a peptide-related or longevity protocol and want objective laboratory monitoring after an initial period, particularly when baseline blood results are available for comparison.
Review changes after approximately 8–12 weeks - Compare key laboratory markers with pre-treatment or earlier results to identify meaningful trends.
Monitor glucose and insulin regulation - Review Fasting Glucose, Fasting Insulin, HOMA-IR and HbA1c together rather than relying on a single glucose measurement.
Review hormone changes - Assess Total Testosterone, Free Testosterone, SHBG, Oestradiol, DHEA-S, Prolactin and Progesterone.
Monitor IGF-1 - Review IGF-1 where growth hormone-related signalling is clinically relevant to the protocol being followed.
Check thyroid function - Measure TSH, FT3 and FT4 within the same follow-up profile.
Assess cardiovascular and metabolic markers - Review a Lipid Profile alongside glucose and insulin measurements.
Monitor kidney function - Creatinine and eGFR provide information about kidney filtration and can be compared with baseline values.
Review nutritional markers - Assess Vitamin D, Magnesium and Zinc during longer-term monitoring.
Arrange private peptide-related blood testing in London - Access follow-up laboratory testing through London Blood Tests with clinic and mobile collection options.
Symptoms and Reasons to Consider the Peptide Monitoring Profile
You may wish to consider the Peptide Monitoring Profile (8–12 weeks) if you are undergoing a peptide-related protocol and want to monitor laboratory changes, particularly if you have baseline results available for comparison.
You are approaching 8–12 weeks of a protocol - Follow-up testing can provide objective information about how key biomarkers compare with your starting values.
Unexpected fatigue or reduced energy - Thyroid, glucose, hormone and nutritional markers may provide useful laboratory context.
Changes in body composition or weight - Fasting Glucose, Fasting Insulin, HOMA-IR, HbA1c, thyroid markers and the Lipid Profile may be relevant to review.
Changes in libido or sexual wellbeing - Total Testosterone, Free Testosterone, SHBG, Oestradiol and Prolactin may provide useful hormonal information.
Changes in menstrual cycle or hormone-related symptoms - Oestradiol, Progesterone, Prolactin, testosterone-related markers and thyroid hormones may provide relevant laboratory information.
Concerns about blood sugar regulation - Fasting Glucose, Fasting Insulin, HOMA-IR and HbA1c provide complementary information about glucose metabolism.
Wanting to monitor IGF-1 - IGF-1 can be followed when clinically relevant, particularly where a protocol may interact with growth hormone signalling.
Changes in cholesterol or cardiovascular markers - LIPP can be compared with baseline results to identify changes in cholesterol and triglyceride measurements.
Muscle cramps, weakness or reduced recovery - Magnesium, Vitamin D, Zinc and thyroid markers may provide useful context, although these symptoms have many possible causes.
Wanting objective follow-up rather than relying on symptoms alone - Laboratory monitoring can identify measurable changes even when a person feels well.
The purpose of monitoring is to identify changes in laboratory markers, not to prove that a peptide is working or that continued use is safe. A normal blood test cannot confirm the purity, identity or sterility of a peptide product and cannot exclude every potential adverse effect.
Symptoms such as fatigue, palpitations, severe abdominal pain, persistent vomiting, significant weakness, visual disturbance, severe headache, chest pain or breathing difficulty should not simply be managed by waiting for routine monitoring blood tests. New or severe symptoms require appropriate medical assessment.
Results are most meaningful when compared with baseline measurements and interpreted alongside the exact protocol, dose, duration, symptoms, medical history, medication and supplements.
How to Prepare
Do not alter or stop a prescribed treatment simply to improve a blood test result unless advised by the clinician responsible for your care. If you are using a peptide product outside medical supervision, laboratory testing does not substitute for appropriate clinical assessment.
How to Book Your Peptide Monitoring Profile in London
Booking your Peptide Monitoring Profile (8–12 weeks) with London Blood Tests is simple and designed to fit around your schedule.
Choose the Peptide Monitoring Profile (8–12 weeks)
Select the Peptide Monitoring Profile online and review the 22 included biomarkers and laboratory profiles before booking.
Select your sample collection option
Choose an in-clinic blood draw (+£35) or a home or hotel phlebotomy visit (+£60) where a qualified phlebotomist collects your sample.
Attend your appointment
Attend your appointment after following the fasting and preparation instructions. A trained professional will collect your blood sample safely and efficiently.
Laboratory analysis
Your sample is sent to the laboratory, where TSH, FT3, FT4, Free Testosterone, Total Testosterone, Sex Hormone Binding Globulin (SHBG), Oestradiol, DHEA-S, IGF-1, Fasting Glucose, Fasting Insulin, HOMA-IR, HbA1c, Creatinine, eGFR, LIPP, Vitamin D, Magnesium, Zinc, hs-CRP, Prolactin and Progesterone are assessed.
Receive your results securely
Your results are sent securely by email, ready to compare with your baseline results and discuss with a GP, endocrinologist or other suitably qualified clinician.
When Will I Receive My Results?
The expected turnaround time for the Peptide Monitoring Profile (8–12 weeks) is approximately 1 business day.
Results are sent securely by email once laboratory analysis and authorisation are complete. Turnaround normally begins when the laboratory receives your sample rather than necessarily from the time the blood is collected.
Some specialist measurements may occasionally require repeat analysis, additional quality checks or further laboratory review, which can extend the expected turnaround.
Understanding Your Results
The most useful way to interpret a monitoring profile is usually to compare it with your baseline results. Small changes may reflect normal biological or laboratory variation, while larger or persistent changes may warrant further assessment depending on the biomarker and clinical circumstances.
Hormonal results should be interpreted together. Total Testosterone can be considered alongside Free Testosterone and SHBG, while Oestradiol, Prolactin, Progesterone and DHEA-S add further hormonal context. IGF-1 requires age-specific interpretation and should not be viewed as a direct measurement of peptide effectiveness.
Metabolic results should also be considered as a group. Fasting Glucose, Fasting Insulin and HOMA-IR provide information about fasting glucose-insulin regulation, while HbA1c reflects a longer period. The Lipid Profile provides additional cardiovascular and metabolic context.
A result within the laboratory reference range does not prove that a protocol is safe, while an abnormal result does not automatically mean that a peptide caused the change. Results should be interpreted alongside your baseline values, symptoms, protocol, medicines, supplements, diet, exercise and medical history.
Why Book With London Blood Tests?
Private peptide monitoring blood testing in London - Access targeted follow-up laboratory testing through London Blood Tests.
Designed for 8–12 week follow-up - Review key biomarkers after an initial period and compare them with baseline measurements.
Hormonal and metabolic monitoring - Assess sex hormones, thyroid markers, IGF-1, glucose, insulin and HOMA-IR within one profile.
Cardiovascular and kidney markers - Review LIPP, Creatinine and eGFR alongside broader metabolic results.
Nutritional and inflammatory markers - Include Vitamin D, Magnesium, Zinc and hs-CRP within the same assessment.
Clinic and home visit options - Choose an in-clinic blood draw or arrange home or hotel phlebotomy depending on location and availability.
Secure laboratory results by email - Receive your authorised report securely once laboratory processing is complete.
Optional clinical interpretation - Results can be discussed separately with a GP or suitably qualified healthcare professional where appropriate.
Private Peptide Monitoring Profile Blood Test Profile in London
London Blood Tests provides the Peptide Monitoring Profile (8–12 weeks) in London for people who want to monitor relevant laboratory markers during a peptide-related or longevity protocol.
The profile focuses on hormones, IGF-1, thyroid function, glucose and insulin regulation, cardiovascular markers, kidney filtration, inflammation and selected nutritional markers. It can be particularly useful when results are compared with a pre-protocol baseline using similar preparation and collection conditions.
Clinic appointments are available alongside home and hotel phlebotomy depending on location and availability, providing flexible options for people looking for a private peptide blood test in London or follow-up monitoring near them.
London Blood Tests provides laboratory testing rather than peptide product authentication. The profile cannot determine whether a peptide product is genuine, pure or sterile and does not replace medical supervision or clinical assessment.